Cargando…
The current status of beta blockers’ use in the management of hypertension
The invention of beta (β)-blockers culminated in a new era in the treatment of cardiovascular diseases (CD), and changed the course of pharmacology research for years to come. Since the introduction of propranolol into clinical practice in 1964, β-blockers enjoyed a special place in the clinicians’...
Autores principales: | Akbar, Shahid, Alorainy, Mohammad S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362137/ https://www.ncbi.nlm.nih.gov/pubmed/25399206 |
Ejemplares similares
-
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
por: Tomiyama, Hirofumi, et al.
Publicado: (2014) -
Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017) -
Role of α1‐blockers in the current management of hypertension
por: Li, Hua, et al.
Publicado: (2022) -
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
por: Haddiya, Intissar, et al.
Publicado: (2023) -
Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)